Clinical Risk & Regulatory Operations
The regulatory obligations that sit on daily clinical operations: EMTALA screening and transfer duties, informed consent processes, restraint and seclusion under the Conditions of Participation, ligature risk and environmental safety assessment, workplace violence prevention, patient identification, medication safety including high-alert medications and barcode administration, alarm management, transitions of care, and utilization review including inpatient versus observation status. Written for risk managers and compliance staff who own the requirement.
Guides
DVT Prophylaxis Compression Stockings: Grading and Selection Guide
How graduated-compression mmHg grading works, how anti-embolism stockings differ from ambulatory compression stockings, and the actual clinical decision behind mechanical DVT prophylaxis in a hospital unit.
CAUTI Prevention Bundle: Catheter Care and Compliance
The CAUTI-prevention bundle elements — appropriate-use criteria, aseptic insertion, closed-drainage-system maintenance, and daily necessity review — with an audit checklist for each.
CMS Patient Rights Under 42 CFR 482.13: A Compliance Map
42 CFR 482.13 is the broadest Condition of Participation by subject matter — eight standards in one section number. This guide maps all eight (notice, grievance process, exercise of rights, privacy/safety, confidentiality, restraint/seclusion, visitation) and the documentation each one drives.
Fall Prevention Program Design: Screening Tools, Risk-Tiered Interventions, and the Post-Fall Huddle
A program-design guide for patient-safety and quality leaders: choosing between the Morse Fall Scale and Hendrich II, building risk-tiered intervention bundles, running a post-fall huddle, and benchmarking the fall-with-injury rate.
Enterprise Risk Management in Healthcare: The Risk-Domain Taxonomy
How ASHRM’s eight-domain enterprise risk management framework applies to a hospital, how it differs from traditional clinical risk management, and how to build a risk register and heat map that reports to the board.
ISMP Targeted Medication Safety Best Practices: A Hospital Self-Assessment Checklist
ISMP’s Targeted Medication Safety Best Practices, organized into a numbered self-assessment checklist hospital patient-safety, pharmacy, and quality teams can walk through and act on.
Elopement Risk Assessment: Screening Criteria and Safeguards by Unit Type
Elopement risk assessment differs meaningfully by unit type: legal status and acute symptoms drive screening on behavioral health units, cognitive impairment and wandering history drive it on dementia-care units, and custody/capacity drive it on pediatric units. This guide covers screening criteria, observation-level tiers, environmental and technology safeguards, and the search-and-notification protocol when a patient is found missing.
Workplace Violence Prevention in Healthcare: Joint Commission Standards and the OSHA General Duty Clause
The Joint Commission requires hospitals to run a documented workplace violence prevention program (risk assessment, reporting system, post-incident support). OSHA has no matching standard of its own — it enforces through the General Duty Clause instead. This guide covers what each requires and how to build one program that satisfies both.
Safe Medical Devices Act Reporting Duties: The User-Facility Compliance Checklist
What the Safe Medical Devices Act requires of hospitals: device-related death and serious-injury reports, the 10-workday clock, and the annual FDA summary.
Hospital Formulary Management: The Addition, Removal, and Non-Formulary Request Process
A practical governance guide to the hospital formulary addition/removal decision process, P&T committee review criteria, non-formulary request pathways, and therapeutic-interchange protocols.
Pharmacy and Therapeutics (P&T) Committee Charter: Membership, Voting, and Conflict-of-Interest Requirements
What a hospital P&T committee charter must actually specify: voting membership and quorum, the evidence-based criteria a formulary decision has to meet, and the conflict-of-interest policy for both committee members and requesting prescribers — sourced from ASHP’s current guideline and the underlying CMS Condition of Participation.
Retained Surgical Item Prevention: Counts, Adjunct Technology, and the Cases Where a Correct Count Still Fails
The AORN counting protocol, what to do when a count fails to reconcile, RF and barcode adjunct technology, and the high-risk case types where a correct count still misses a retained item.
Opioid Stewardship Programs: Prescribing Defaults, PDMP Checks, and Naloxone Triggers
A practical design guide to hospital opioid stewardship programs: prescribing guidelines by procedure type, PDMP-check integration into the ordering workflow, naloxone co-prescribing triggers, and the governance structure and metrics that keep the program running.
The Medicare Outpatient Observation Notice (MOON): Delivery Rules, Required Content, and the Status Decision Behind It
The MOON’s 36-hour delivery deadline, required written content, oral-explanation and signature rules, and how it follows from the two-midnight inpatient-vs-observation decision.
Barcode Medication Administration Implementation: Workflow, Overrides, and Workaround Patterns
How to redesign bedside workflow around BCMA, structure override-reason tracking, and read the specific override patterns in your own data that signal a real workaround problem rather than a legitimate exception.
Adverse Drug Event Surveillance: Trigger Tools and Pharmacy-Based Screening
Voluntary incident reports catch only a fraction of adverse drug events. This guide covers the trigger-tool and pharmacy-based screening methods hospitals use for active ADE surveillance, and how findings feed the medication safety program.
High-Alert Medications: the ISMP List and How to Attach a Real Safeguard to Every Entry
ISMP’s List of High-Alert Medications names the drug classes where a single error can be catastrophic. How independent double-checks, standardized concentrations, and auto-stop orders map to specific failure modes, and how to turn the national list into an institution-specific one with a safeguard attached to every entry.
Building and Maintaining a Look-Alike/Sound-Alike (LASA) Medication List
How to build a LASA medication list from ISMP’s list and your own dispensing data, and the storage, order-entry, and independent double-check strategies that reduce look-alike/sound-alike risk beyond tall man lettering.
Important Message from Medicare: IM Delivery Timing Rules and Compliance Failures
The Important Message from Medicare (CMS-10065) has to be delivered within 2 days of admission, again within 2 days of discharge, and signed each time — unless the short-stay exception applies. Here is the exact timing rule and the failures CMS cites most.
Two Patient Identifiers: The Approved List, and Where the Requirement Applies
What the Joint Commission’s two-patient-identifier requirement actually covers: the approved identifier list, why room number is explicitly excluded, and the specific verification points — specimen collection, medication and blood product administration, and procedures — where it applies.
SBAR Handoff Communication: Worked Scripts and the Failure Modes It Prevents
How SBAR structures a nurse-to-physician escalation call and a shift-to-shift handoff, worked scripts for both, the specific failure modes the structure is designed to prevent, what the evidence actually shows, and what the Joint Commission requirement does and does not mandate.
CPHRM Certification: Eligibility Routes, the Five Exam Domains, and Recertification
What AHA-CC and ASHRM actually publish for the CPHRM credential: the three education-plus-experience eligibility routes, the five exam content domains (and the one thing AHA-CC does not publish about them), exam fees, and the three-year, 45-hour recertification cycle.
Tall Man Lettering: Two Different Lists, the CD3 Rule, and Making It Hold Across Every Screen
FDA and ISMP maintain two separate, non-matching tall man lettering lists. How the CD3 capitalisation rule works, how to apply the convention consistently across EHR pick-lists, pharmacy labels, shelf tags, ADC screens and infusion pumps, and what the mixed experimental evidence actually supports.
Medication Use Evaluation (MUE): Criteria, Sampling, the Data Form, and the P&T Report
A step-by-step procedure for running a medication use evaluation in a health system: establishing the trigger, writing criteria and thresholds, defining the sampling frame, building the data-collection form, analysing for cause, and structuring the report the P&T committee acts on — with the ASHP-sourced distinction between an MUE, a DUE/DUR and a chart audit.
Rapid Response Team Activation Criteria: Charter, Staffing Model, and Programme Measures
A programme-design guide to rapid response teams: the afferent and efferent limbs, what accreditation actually requires, the activation criteria card, family activation via Condition H, the charter, the activation record, and the measures a board will ask for — with an honest account of the contested evidence.
Early Warning Score Implementation: Choosing a Score, Calibrating the Threshold, and Managing Alarm Burden
An implementation guide to early warning scores for deteriorating-patient programme leads: choosing between NEWS2, MEWS and machine-learning scores, calibrating trigger thresholds locally under NICE CG50 1.9, writing an escalation policy that survives audit, designing the handoff into the rapid response system, and doing the alarm-burden arithmetic before the threshold is set.
The Two-Midnight Rule: Deciding Inpatient vs. Observation, Case by Case
The two-midnight rule turns on the admitting practitioner’s documented expectation, not on how long the patient actually stayed. The decision sequence reviewers apply, why the benchmark clock starts before the admission order, the case-by-case exception, and what changes as the Inpatient-Only list is phased out from 2026.
Condition Code 44: The UR Committee Procedure and Its Paperwork Trail
Condition Code 44 changes an inpatient admission to outpatient before discharge, but only if all four CMS conditions are met and documented. The utilization review committee rules at 42 CFR 482.30, the observation-order trap, and which beneficiary notice applies now that the Medicare Change of Status Notice is mandatory.
Ligature Risk Assessment: CMS Expectations and How to Run One
CMS does not regulate ligature points directly — the obligation runs through the patient’s right to receive care in a safe setting at 42 CFR 482.13(c)(2), as interpreted in memorandum QSO-23-19-Hospitals (July 2023), which supersedes the 2017 clarification most guidance still cites. This guide sets out the three elements CMS expects, why universal hardening is explicitly not required, and a defensible assessment procedure.
Restraint and Seclusion Under the CMS Conditions of Participation (42 CFR 482.13)
Restraint and seclusion in Medicare-participating hospitals are governed by 42 CFR 482.13(e)-(g). Almost every compliance question turns on one determination: is this use for violent or self-destructive behaviour, or non-violent restraint to protect physical safety? This guide sets out the order time limits by age, the 1-hour face-to-face evaluation, monitoring and documentation requirements, staff training content, and the death-reporting rules — with the regulatory text each comes from.
Universal Protocol and the Surgical Safety Checklist: What the Time-Out Actually Requires
The Universal Protocol requires pre-procedure verification, site marking, and a time-out before every procedure. This guide covers what each component requires, how the WHO Surgical Safety Checklist maps onto it, and where time-outs commonly fail in practice.
Medication Reconciliation: The Five-Step Process and What the Evidence Shows
Medication reconciliation compares a patient’s actual medications against what’s being ordered at admission, transfer, and discharge. The five-step process is well established; what’s less well known is that AHRQ’s own review finds the evidence for its effect on outcomes genuinely mixed.
EMTALA: Screening, Stabilization, and Transfer Rules
EMTALA (42 CFR 489.24) requires hospitals with an emergency department to screen and stabilize every patient regardless of ability to pay. The compliance judgment calls sit in what counts as a screening exam, when a patient is stabilized, and what makes a transfer appropriate.
